GE HealthCare Technologies Inc., a subsidiary of General Electric, focuses on advancing healthcare through innovative medical technologies and solutions. They specialize in medical imaging, diagnostics, patient monitoring systems, and healthcare IT.
GE HealthCare Technologies Inc., headquartered in Chicago, Illinois, specializes in the development, manufacturing, and global marketing of a wide range of products, services, and digital solutions essential for the diagnosis, treatment, and monitoring of patients worldwide. The company operates through four distinct segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each focusing on specific aspects of medical technology innovation.
Within the Imaging segment, GE HealthCare Technologies offers advanced solutions including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and specialized products for women's health. The Ultrasound segment provides medical devices tailored for screening, diagnosis, and treatment across various clinical disciplines such as radiology, primary care, cardiovascular health, and women's health, alongside surgical visualization and guidance technologies.
The Patient Care Solutions segment enhances healthcare delivery through a portfolio of medical devices, consumables, services, and digital healthcare solutions. This segment includes patient monitoring systems, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal-infant care products, and comprehensive service offerings. Additionally, the Pharmaceutical Diagnostics segment supplies essential diagnostic agents for CT, MR, X-ray, and nuclear medicine imaging, including contrast media pharmaceuticals and molecular imaging agents. With a focus on continuous innovation and strategic partnerships, such as its collaboration with Mass General Brigham in artificial intelligence, GE HealthCare Technologies remains at the forefront of advancing medical technology to improve patient outcomes globally.